SlideShare a Scribd company logo
Building up a brand in an
unprecedented environment
Nov.2016
A.Vogel in Greece
1
1. Introduction
2. The country: Greece [& Cyprus]
3. The organization: ICP
4. ICP„s strategy and implementation
5. Conclusion
A.Vogel Brand Case Study
1
“History” / starting point 2009 A.D.
1.1
We are not allowed to forget our boundary conditions, and at the same
time we have to keep handling “noise” caused by external factors.
A.Vogel Brand Case Study
A.Vogel Brand Case Study
1.2
Seven years ago we started structuring a new
for the local standards model of organization,
to deliver solutions to the health and beauty
market. Some people said it couldn‟t be done!
“When the going gets tough,
the tough get going”
Wall Street motto applicable to the current tough Greek
reality
1
A.Vogel Brand Case Study
1.3
1. WHO: ICP
2. WHAT: Penetration / sustainability / growth of A.Vogel brand
in Greece and Cyprus
3. WHERE: Greece and Cyrpus
4. WHEN: 2009 onwards
5. WHY: Function of [tradition, innovation, quality]
6. HOW: People mainly – because everything in life is
developed / applied by people
1
ICP has managed to deliver Growth through:
• disruption / “my way or highway” [Pat Riley]
• innovation and
• adaptability
1.4
A.Vogel Brand Case Study
1
The most rewarding things you
do in life are often the ones that
look like they cannot be done.
Arnold Palmer
1.5
A.Vogel Brand Case Study
1
1.6
A.Vogel Brand Case Study
Acropolis of Athens: the core element of the cradle of
western civilization
A.Vogel: the core element of both Bioforce and A.Vogel
brand
1
The country
2.1
A.Vogel Brand Case Study
[The bright side of it]
1
2.2
Greece‟s outlook / key facts
• Even a “blind” person can easily realize that Greece is a place of
testing “innovative” policies.
• Population 10,8 million
• GDP: 170 billion € [30% less than the beginning of crisis]
• Number of pharmacies 10.300
• Average annual turnover of pharmacies has gone down to slightly
above 400K € in 2015, from more than 700K € back in 2009, (fall in
the range of 40%)
A.Vogel Brand Case Study
1
Parameters / factors of the performance evaluation of a
partner:
- Quantitative: - Years of cooperation
- GDP per capita variation
- Population of the country
- Qualitative: - Psychology
- Stability of the country / market and
risks associated
2.3
A.Vogel Brand Case Study
1
ICP Profile
ICP commercializes top notch parapharmaceutical products of proven quality, safety and efficacy.
Company Background:
• Founded: 2003
• Based in Moschato, 5km from Acropolis
• Golden section of mgt by objectives and mgt by example
• 24 Employees, 16 of which with University degrees
• Subdistributors: In Thessaloniki – 8 people (5 salesmen), Crete and Cyprus
Portfolio of Innovative Products
10.300 pharmacies, out of which >3000 are ICP‟s customers
Values:
Integrity and Quality = Consistency and Continuity
Mission:
To offer safe, effective and or premium quality products to our customers / end-consumers in the area of nutritional /
food supplements and parapharmaceuticals in general so as to fully cover their needs building a trustworthy and long-
lasting relationship. To efficiently support our direct customers (pharmacists) contributing substantially in strengthening
/ enhancing their operation.
Vision:
To position / establish the brands of its portfolio in the market as the first choice in their respective
categories and as a result to be regarded as the most reputable supplier in the field
3.1
A.Vogel Brand Case Study
1
Sales / scientific team of 13 persons (sales & medical
rep) for Central-Southern Greece (external distributor
for areas of Northern Greece & Crete)
- Personnel visits both pharmacies and doctors
- 2 people dedicated to doctors in private hospitals
- Person who educates staff of key customers and
communicates the brand values to consumers in large
POS
What substantially matters in an organization is whatever
crosses its borders
3.2
A.Vogel Brand Case Study
1
ICP has “adopted” Alfred Vogel’s philosophy
“We do not sell products – we offer services
of high quality to both mid-customers and
end-consumers.” [i.e. diffusion of knowledge
/ communication and relationships]
3.3
A.Vogel Brand Case Study
1
3.4
A.Vogel Brand Case Study
1
Ecosystem of ICP:
Besides both suppliers and customers
- Internal: Direct: - Management
- Sales force
- Business development
- Marketing
- Warehouse
Indirect / outsourcing:
- Legal
- Logistics
- Regulatory
- Accounting
- IT
- Media / SoMe
3.5
A.Vogel Brand Case Study
1
Ecosystem of ICP:
- External: - Market / end consumer
- Competition
- Regulatory authorities
- Taxation / VAT
3.6
A.Vogel Brand Case Study
1
ICP adds significant value and support as a strategic
partner to its customers and end-consumers
People: we value people at every level who lead by example, take pride in what
they do and inspire others.
Teamwork: we value working together to achieve common goals which is the
foundation of our success.
Proven track record: demonstrated through past performance.
Able to deliver an affordable solution without complexity: Ad-hoc brand
management.
Flexible and bespoke: listening to the exact needs.
Work ethic: committed to excellence and how we achieve it.
Integrity: we do what is right for our customers, clients and ourselves.
3.7
A.Vogel Brand Case Study
1
Our strong corporate values drive our business and
we seek the same values in both our customers and
suppliers
3.8
A.Vogel Brand Case Study
1
VISIONARY
We think differently and are not afraid of
competition.
KNOWLEDGEABLE
We have – considering our size – the strongest
team in our field. Our language is confident but
friendly. We avoid jargon and put the customer
first.
TRUSTWORTHY
We are honest, approachable and engaging. The
trusted company.
HUMAN
Our world revolves around our customers and
their needs.
3.9
A.Vogel Brand Case Study
ICP manages a wide portfolio of top-notch products.
1
Even in this turbulent business environment
we do not stop investing:
Internally: - people
- infrastructure
- IT
Externally / in an organization what really matters is what it
crosses its borders:
- marketing
- SoMe / particular emphasis
If adjustment of costs is necessary this does not affect
quality of service.
3.10
A.Vogel Brand Case Study
1
MARKETING ACTIVITIES
A. ACTIVITIES MATERIALIZED RECENTLY:
• Online marketing
• Offline marketing
• Above the line
• Below the line
B. Activities under consideration:
• Same modus operandi taking into consideration certain constrains / restrictions
Focus on quantifiable vs. non quantifiable means of marketing
Evaluation of ROI = f[money, time, opportunity cost, effort, commitment]
3.11
A.Vogel Brand Case Study
1
SWOT analysis
S [trenghts]:
- The personnel of the company / synthesis of the team
- The financial stability [zero debt]
W [eaknesses]:
- Different sites [mgt and warehouse]
- Lag in execution / implementation through sub-distributors
O [pportunities]:
- Shift of consumers towards relative affordable products of undisputed
quality
- perception of the brand by still growing customer basis / pharmacists
T [hreats]:
- Ongoing crisis with considerable reduction of the purchasing power
- New local players in the segment / local pharma companies adopt the
widely applied trend of creation of OTC business units
3.12
A.Vogel Brand Case Study
1
Needs of the market / industry
4.1
A.Vogel Brand Case Study
1
Strong brands have to have clear positioning.
A.Vogel brand is positioned between medicines and
food supplements primarily because it is backed by
science.
4.2
A.Vogel Brand Case Study
1
4.3
ICP vs A.Vogel
A.Vogel Brand Case Study
1
With holistic and coherent approach
With clear policy / planning
With the right execution / implementation
With the right people and mindset
4.4
A.Vogel Brand Case Study
1
The Strategy
For a company to succeed, a clear
pathway aligned to its business
plan and strategy is key.
The strategy is a vital component in
the Company armory. It should
have equal value and importance to
the brands and their protection.
4.5
A.Vogel Brand Case Study
1
Where does the strategy start?
Drill back down to what is important
and what is valuable and start with
two questions:
What is my product?

Where/what are the opportunities?
Sounds simple but....!
4.6
A.Vogel Brand Case Study
1
The wider strategy
What defines each? Who controls and regulates them?
Our strategy is a three dimensional tool.
 Level 1: Commercial – What is this we want to make happen?
 Level 2: Geographical – Full coverage
 Level 3: Steps - What are the clearly and precisely defined steps [KISS] to
achieve this?
4.7
A.Vogel Brand Case Study
1
The wider strategy
“If you know the enemy and know yourself, you need not fear the result of a
hundred battles.
If you know yourself but not the enemy, for every victory gained you will also suffer
a defeat.
If you know neither the enemy nor yourself, you will succumb in every battle.”
Sun Tzu, The art of War
4.8
A.Vogel Brand Case Study
1
OPTION #1
If You sit down by a river
bank, and wait long
enough, You‟ll see bodies
of Your enemies float by
4.9
A.Vogel Brand Case Study
1
OPTION #2
Master completely a
different way of marketing
4.10
A.Vogel Brand Case Study
1
OPTION #3
Create ecosystems
Ecosystems are determined by parameters
- Fully controlled
- Semi / quasi controlled
- Non-controlled
The goal has to be the optimization of the controlled
and semi-controlled parameters so as to
counterbalance the potential negative input from the
non-controlled ones.
4.11
A.Vogel Brand Case Study
1
OPTION #4
Be the disruptor
4.12
A.Vogel Brand Case Study
1
OPTION #5
“Be the disruptor in things you control.
Be adaptive to things you do not control.”
- SM
4.13
A.Vogel Brand Case Study
1
A yearly planning cycle driven mainly by Marketing
IMC [internal model control] vis a vis planning /
perpetual trial and error process
Brand
plans
Minor
adjustments
Trimester
modifications
Brand
reconsideration
4.14
A.Vogel Brand Case Study
1
4.15
A.Vogel Brand Case Study
1
Right people / organization & mindset / implementation
- execution
4.16
A.Vogel Brand Case Study
The final part of the jigsaw – tactics – the way we implement it!
1
Brand overview / SWOT analysis
S [trenghts]:
- Knowledge of the caliber of the brand and its specific weight
/ “second nature” by ICP’s personnel
W [eaknesses]:
- Regulatory status
O [pportunities]:
- Optimization of the two parameter function of pricing and
quality.
- Perception from customers and consumers.
T [hreats]: Constraints for efficient marketing due to regulation
and operational gross margins
4.17
A.Vogel Brand Case Study
1
Dominant factors for the growth of the A.Vogel brand
in our market:
- Regulatory compliance [prerequisite]
- Margins [financially coherent P&L] for supporting the
efficient awareness and availability of the brand
4.18
A.Vogel Brand Case Study
1
CONCLUSIONS
• People – People – People: the cornerstone / most critical parameter
Give me the right people and I will accomplish [almost] everything. - SM
[Give me a place to stand and I will move the world – Archimides]
• Requirement for common sense [which is not that common], both inside and
outside of ICP’s ecosystem
• Capitalization on past experiences incorporating other partners’ policies
“Man has always learnt from the past. After all, you can’t learn history in
reverse.” – SM
• “Ta panta rei” = [everything is under perpetual variation ie. nothing is constant /
stable = dynamic and not static] -Heracletus
• “I am pessimistic because I am pragmatic and optimistic because I dream.” -
Noam Chomsky
5.1
A.Vogel Brand Case Study
Thank you!

More Related Content

What's hot

Sarbec Cosmetics France India Marketing Strategy
Sarbec Cosmetics France   India Marketing StrategySarbec Cosmetics France   India Marketing Strategy
Sarbec Cosmetics France India Marketing Strategy
Bhuvan Mathur
 
New product development
New product developmentNew product development
New product developmentshdeepa
 
New product development & its process
New product development  & its processNew product development  & its process
New product development & its process
Asmit Patrapada
 
Analysis on Product Development in the Food and Beverage Industry and Frito Lay
Analysis on Product Development in the Food and Beverage Industry and Frito LayAnalysis on Product Development in the Food and Beverage Industry and Frito Lay
Analysis on Product Development in the Food and Beverage Industry and Frito LayDustin Fontenot
 
EsBrand 2012 - TOP 100 Spanish Brands
EsBrand 2012 - TOP 100 Spanish BrandsEsBrand 2012 - TOP 100 Spanish Brands
EsBrand 2012 - TOP 100 Spanish Brands
MPP Consulting
 
New product development report Marketing (perfume)
New product development report Marketing (perfume)New product development report Marketing (perfume)
New product development report Marketing (perfume)
Umair Ijaz
 
New product failure and success by www.jobbazzar.com
New product failure and success by www.jobbazzar.comNew product failure and success by www.jobbazzar.com
New product failure and success by www.jobbazzar.com
www.Jobbazzar.com
 
Lancome
Lancome Lancome
Lancome
Justin Scruggs
 

What's hot (9)

Sarbec Cosmetics France India Marketing Strategy
Sarbec Cosmetics France   India Marketing StrategySarbec Cosmetics France   India Marketing Strategy
Sarbec Cosmetics France India Marketing Strategy
 
New product development
New product developmentNew product development
New product development
 
New product development & its process
New product development  & its processNew product development  & its process
New product development & its process
 
Analysis on Product Development in the Food and Beverage Industry and Frito Lay
Analysis on Product Development in the Food and Beverage Industry and Frito LayAnalysis on Product Development in the Food and Beverage Industry and Frito Lay
Analysis on Product Development in the Food and Beverage Industry and Frito Lay
 
EsBrand 2012 - TOP 100 Spanish Brands
EsBrand 2012 - TOP 100 Spanish BrandsEsBrand 2012 - TOP 100 Spanish Brands
EsBrand 2012 - TOP 100 Spanish Brands
 
New product development report Marketing (perfume)
New product development report Marketing (perfume)New product development report Marketing (perfume)
New product development report Marketing (perfume)
 
Resume Shalaka
Resume ShalakaResume Shalaka
Resume Shalaka
 
New product failure and success by www.jobbazzar.com
New product failure and success by www.jobbazzar.comNew product failure and success by www.jobbazzar.com
New product failure and success by www.jobbazzar.com
 
Lancome
Lancome Lancome
Lancome
 

Viewers also liked

June 2012 IP Legal Minute
June 2012 IP Legal MinuteJune 2012 IP Legal Minute
June 2012 IP Legal Minute
khorton123
 
がん治療 (血管内治療):動脈血栓術の基本概念と各種症例
がん治療 (血管内治療):動脈血栓術の基本概念と各種症例がん治療 (血管内治療):動脈血栓術の基本概念と各種症例
がん治療 (血管内治療):動脈血栓術の基本概念と各種症例
HealthcareBitStation
 
Glass sky walk - Zhangjiajie
Glass sky walk - ZhangjiajieGlass sky walk - Zhangjiajie
Glass sky walk - ZhangjiajieNizam Zan
 
Expo70 project presentation
Expo70 project presentationExpo70 project presentation
Expo70 project presentation
Amna Dhaheri
 
IGCSE geography-Case study-Osaka kobe
IGCSE geography-Case study-Osaka kobeIGCSE geography-Case study-Osaka kobe
IGCSE geography-Case study-Osaka kobe
Ebin Robinson
 
Glass Skywalk In Zhangjiajie, China
Glass Skywalk In Zhangjiajie, ChinaGlass Skywalk In Zhangjiajie, China
Glass Skywalk In Zhangjiajie, China
Jodiesjourneycom
 
Seminar on capital gate building
Seminar on capital gate buildingSeminar on capital gate building
Seminar on capital gate building
Nayan Rao
 
Glass Bridge-China
Glass Bridge-ChinaGlass Bridge-China
Glass Bridge-ChinaBiaEsteves
 
5.ar.tadao ando
5.ar.tadao ando5.ar.tadao ando
5.ar.tadao ando
Hetali Bhatt
 
Ribbon Development With Case Study Of Aydin
Ribbon Development With Case Study Of Aydin Ribbon Development With Case Study Of Aydin
Ribbon Development With Case Study Of Aydin
Pathik
 
Grand Canyon Skywalk
Grand Canyon SkywalkGrand Canyon Skywalk
Grand Canyon Skywalk
MaMaT CyBeR
 
Advance road transportation system ppt
Advance road transportation system pptAdvance road transportation system ppt
Advance road transportation system ppt
Abdul Aziz
 
837 Washington
837 Washington837 Washington
837 Washington
Gilsanz Murray Steficek
 

Viewers also liked (13)

June 2012 IP Legal Minute
June 2012 IP Legal MinuteJune 2012 IP Legal Minute
June 2012 IP Legal Minute
 
がん治療 (血管内治療):動脈血栓術の基本概念と各種症例
がん治療 (血管内治療):動脈血栓術の基本概念と各種症例がん治療 (血管内治療):動脈血栓術の基本概念と各種症例
がん治療 (血管内治療):動脈血栓術の基本概念と各種症例
 
Glass sky walk - Zhangjiajie
Glass sky walk - ZhangjiajieGlass sky walk - Zhangjiajie
Glass sky walk - Zhangjiajie
 
Expo70 project presentation
Expo70 project presentationExpo70 project presentation
Expo70 project presentation
 
IGCSE geography-Case study-Osaka kobe
IGCSE geography-Case study-Osaka kobeIGCSE geography-Case study-Osaka kobe
IGCSE geography-Case study-Osaka kobe
 
Glass Skywalk In Zhangjiajie, China
Glass Skywalk In Zhangjiajie, ChinaGlass Skywalk In Zhangjiajie, China
Glass Skywalk In Zhangjiajie, China
 
Seminar on capital gate building
Seminar on capital gate buildingSeminar on capital gate building
Seminar on capital gate building
 
Glass Bridge-China
Glass Bridge-ChinaGlass Bridge-China
Glass Bridge-China
 
5.ar.tadao ando
5.ar.tadao ando5.ar.tadao ando
5.ar.tadao ando
 
Ribbon Development With Case Study Of Aydin
Ribbon Development With Case Study Of Aydin Ribbon Development With Case Study Of Aydin
Ribbon Development With Case Study Of Aydin
 
Grand Canyon Skywalk
Grand Canyon SkywalkGrand Canyon Skywalk
Grand Canyon Skywalk
 
Advance road transportation system ppt
Advance road transportation system pptAdvance road transportation system ppt
Advance road transportation system ppt
 
837 Washington
837 Washington837 Washington
837 Washington
 

Similar to Building up a brand in an unprecedented environment

Essel propack - International Marketing Managment
Essel propack - International Marketing ManagmentEssel propack - International Marketing Managment
Essel propack - International Marketing Managment
Sanjay Vaid (MLE℠)
 
Globalmarketing
GlobalmarketingGlobalmarketing
Globalmarketingmiboyfrend
 
Mtm7 white paper product life cycle analysis
Mtm7 white paper   product life cycle analysisMtm7 white paper   product life cycle analysis
Mtm7 white paper product life cycle analysis
IntelCollab.com
 
Anteo Technologies - New York presentation 2015
Anteo Technologies - New York presentation 2015Anteo Technologies - New York presentation 2015
Anteo Technologies - New York presentation 2015
Matt Sanderson
 
Product and brand discussion
Product and brand discussionProduct and brand discussion
Product and brand discussionStudsPlanet.com
 
Differentiation strategies for the generic industrry
Differentiation strategies for the generic industrryDifferentiation strategies for the generic industrry
Differentiation strategies for the generic industrry
✪ Asa Cox (ThePharmaPartner)
 
sangalang jose carmelo 10 marketing plan
sangalang jose carmelo 10 marketing plansangalang jose carmelo 10 marketing plan
sangalang jose carmelo 10 marketing plan
jcasangalang
 
Unilever Complete
Unilever Complete Unilever Complete
Unilever Complete
NOMAN KHAN
 
Epistem holdings plc (ehp) product pipeline analysis
Epistem holdings plc (ehp)   product pipeline analysisEpistem holdings plc (ehp)   product pipeline analysis
Epistem holdings plc (ehp) product pipeline analysis
CompanyProfile123
 
Nanobiotix - Roadmap 10.12.2014
Nanobiotix - Roadmap 10.12.2014Nanobiotix - Roadmap 10.12.2014
Nanobiotix - Roadmap 10.12.2014
Hermann Henniger
 
Mehmet Tanlak
Mehmet TanlakMehmet Tanlak
Mehmet Tanlak
MEHMET TANLAK
 
Global Marketing Strategy- IOPE
Global Marketing Strategy- IOPEGlobal Marketing Strategy- IOPE
Global Marketing Strategy- IOPEAlicia xiaoxiao li
 
Live Communication 2.0
Live Communication 2.0Live Communication 2.0
Live Communication 2.0
Dagobert Hartmann
 
Product launch disasters and how to avoid them
Product launch disasters and how to avoid themProduct launch disasters and how to avoid them
Product launch disasters and how to avoid them
Cambridge Product Management Network
 
BEXIMCO pharmaceuticals Ltd. - Basic report (MGT 210)
BEXIMCO pharmaceuticals Ltd. - Basic report (MGT 210)BEXIMCO pharmaceuticals Ltd. - Basic report (MGT 210)
BEXIMCO pharmaceuticals Ltd. - Basic report (MGT 210)
Bangladesh Youth Leadership Center (BYLC)
 
Colgate Palmolive Final Presentation 4.27
Colgate Palmolive Final Presentation 4.27Colgate Palmolive Final Presentation 4.27
Colgate Palmolive Final Presentation 4.27Emily Krokstrom
 
Marketing mix Analysis
Marketing mix AnalysisMarketing mix Analysis
Marketing mix Analysis
bappykazi
 
product planning.pptx
product planning.pptxproduct planning.pptx
product planning.pptx
SoujanyaLk1
 

Similar to Building up a brand in an unprecedented environment (20)

Essel propack - International Marketing Managment
Essel propack - International Marketing ManagmentEssel propack - International Marketing Managment
Essel propack - International Marketing Managment
 
Globalmarketing
GlobalmarketingGlobalmarketing
Globalmarketing
 
Mtm7 white paper product life cycle analysis
Mtm7 white paper   product life cycle analysisMtm7 white paper   product life cycle analysis
Mtm7 white paper product life cycle analysis
 
Anteo Technologies - New York presentation 2015
Anteo Technologies - New York presentation 2015Anteo Technologies - New York presentation 2015
Anteo Technologies - New York presentation 2015
 
Product and brand discussion
Product and brand discussionProduct and brand discussion
Product and brand discussion
 
Differentiation strategies for the generic industrry
Differentiation strategies for the generic industrryDifferentiation strategies for the generic industrry
Differentiation strategies for the generic industrry
 
sangalang jose carmelo 10 marketing plan
sangalang jose carmelo 10 marketing plansangalang jose carmelo 10 marketing plan
sangalang jose carmelo 10 marketing plan
 
Unilever
Unilever Unilever
Unilever
 
Unilever Complete
Unilever Complete Unilever Complete
Unilever Complete
 
Epistem holdings plc (ehp) product pipeline analysis
Epistem holdings plc (ehp)   product pipeline analysisEpistem holdings plc (ehp)   product pipeline analysis
Epistem holdings plc (ehp) product pipeline analysis
 
Nanobiotix - Roadmap 10.12.2014
Nanobiotix - Roadmap 10.12.2014Nanobiotix - Roadmap 10.12.2014
Nanobiotix - Roadmap 10.12.2014
 
middle East
middle Eastmiddle East
middle East
 
Mehmet Tanlak
Mehmet TanlakMehmet Tanlak
Mehmet Tanlak
 
Global Marketing Strategy- IOPE
Global Marketing Strategy- IOPEGlobal Marketing Strategy- IOPE
Global Marketing Strategy- IOPE
 
Live Communication 2.0
Live Communication 2.0Live Communication 2.0
Live Communication 2.0
 
Product launch disasters and how to avoid them
Product launch disasters and how to avoid themProduct launch disasters and how to avoid them
Product launch disasters and how to avoid them
 
BEXIMCO pharmaceuticals Ltd. - Basic report (MGT 210)
BEXIMCO pharmaceuticals Ltd. - Basic report (MGT 210)BEXIMCO pharmaceuticals Ltd. - Basic report (MGT 210)
BEXIMCO pharmaceuticals Ltd. - Basic report (MGT 210)
 
Colgate Palmolive Final Presentation 4.27
Colgate Palmolive Final Presentation 4.27Colgate Palmolive Final Presentation 4.27
Colgate Palmolive Final Presentation 4.27
 
Marketing mix Analysis
Marketing mix AnalysisMarketing mix Analysis
Marketing mix Analysis
 
product planning.pptx
product planning.pptxproduct planning.pptx
product planning.pptx
 

Recently uploaded

How STIs Influence the Development of Pelvic Inflammatory Disease.pptx
How STIs Influence the Development of Pelvic Inflammatory Disease.pptxHow STIs Influence the Development of Pelvic Inflammatory Disease.pptx
How STIs Influence the Development of Pelvic Inflammatory Disease.pptx
FFragrant
 
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptxMaxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
Dr. Rabia Inam Gandapore
 
The Normal Electrocardiogram - Part I of II
The Normal Electrocardiogram - Part I of IIThe Normal Electrocardiogram - Part I of II
The Normal Electrocardiogram - Part I of II
MedicoseAcademics
 
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.GawadHemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
NephroTube - Dr.Gawad
 
BRACHYTHERAPY OVERVIEW AND APPLICATORS
BRACHYTHERAPY OVERVIEW  AND  APPLICATORSBRACHYTHERAPY OVERVIEW  AND  APPLICATORS
BRACHYTHERAPY OVERVIEW AND APPLICATORS
Krishan Murari
 
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...
VarunMahajani
 
Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model Safe
Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model SafeSurat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model Safe
Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model Safe
Savita Shen $i11
 
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdfAlcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Dr Jeenal Mistry
 
Non-respiratory Functions of the Lungs.pdf
Non-respiratory Functions of the Lungs.pdfNon-respiratory Functions of the Lungs.pdf
Non-respiratory Functions of the Lungs.pdf
MedicoseAcademics
 
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptxANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
Swetaba Besh
 
Cervical & Brachial Plexus By Dr. RIG.pptx
Cervical & Brachial Plexus By Dr. RIG.pptxCervical & Brachial Plexus By Dr. RIG.pptx
Cervical & Brachial Plexus By Dr. RIG.pptx
Dr. Rabia Inam Gandapore
 
KDIGO 2024 guidelines for diabetologists
KDIGO 2024 guidelines for diabetologistsKDIGO 2024 guidelines for diabetologists
KDIGO 2024 guidelines for diabetologists
د.محمود نجيب
 
Ocular injury ppt Upendra pal optometrist upums saifai etawah
Ocular injury  ppt  Upendra pal  optometrist upums saifai etawahOcular injury  ppt  Upendra pal  optometrist upums saifai etawah
Ocular injury ppt Upendra pal optometrist upums saifai etawah
pal078100
 
Superficial & Deep Fascia of the NECK.pptx
Superficial & Deep Fascia of the NECK.pptxSuperficial & Deep Fascia of the NECK.pptx
Superficial & Deep Fascia of the NECK.pptx
Dr. Rabia Inam Gandapore
 
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTSARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
Dr. Vinay Pareek
 
Knee anatomy and clinical tests 2024.pdf
Knee anatomy and clinical tests 2024.pdfKnee anatomy and clinical tests 2024.pdf
Knee anatomy and clinical tests 2024.pdf
vimalpl1234
 
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists  Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Saeid Safari
 
263778731218 Abortion Clinic /Pills In Harare ,
263778731218 Abortion Clinic /Pills In Harare ,263778731218 Abortion Clinic /Pills In Harare ,
263778731218 Abortion Clinic /Pills In Harare ,
sisternakatoto
 
Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...
Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...
Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...
Savita Shen $i11
 
Triangles of Neck and Clinical Correlation by Dr. RIG.pptx
Triangles of Neck and Clinical Correlation by Dr. RIG.pptxTriangles of Neck and Clinical Correlation by Dr. RIG.pptx
Triangles of Neck and Clinical Correlation by Dr. RIG.pptx
Dr. Rabia Inam Gandapore
 

Recently uploaded (20)

How STIs Influence the Development of Pelvic Inflammatory Disease.pptx
How STIs Influence the Development of Pelvic Inflammatory Disease.pptxHow STIs Influence the Development of Pelvic Inflammatory Disease.pptx
How STIs Influence the Development of Pelvic Inflammatory Disease.pptx
 
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptxMaxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
 
The Normal Electrocardiogram - Part I of II
The Normal Electrocardiogram - Part I of IIThe Normal Electrocardiogram - Part I of II
The Normal Electrocardiogram - Part I of II
 
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.GawadHemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
 
BRACHYTHERAPY OVERVIEW AND APPLICATORS
BRACHYTHERAPY OVERVIEW  AND  APPLICATORSBRACHYTHERAPY OVERVIEW  AND  APPLICATORS
BRACHYTHERAPY OVERVIEW AND APPLICATORS
 
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...
 
Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model Safe
Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model SafeSurat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model Safe
Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model Safe
 
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdfAlcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
 
Non-respiratory Functions of the Lungs.pdf
Non-respiratory Functions of the Lungs.pdfNon-respiratory Functions of the Lungs.pdf
Non-respiratory Functions of the Lungs.pdf
 
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptxANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
 
Cervical & Brachial Plexus By Dr. RIG.pptx
Cervical & Brachial Plexus By Dr. RIG.pptxCervical & Brachial Plexus By Dr. RIG.pptx
Cervical & Brachial Plexus By Dr. RIG.pptx
 
KDIGO 2024 guidelines for diabetologists
KDIGO 2024 guidelines for diabetologistsKDIGO 2024 guidelines for diabetologists
KDIGO 2024 guidelines for diabetologists
 
Ocular injury ppt Upendra pal optometrist upums saifai etawah
Ocular injury  ppt  Upendra pal  optometrist upums saifai etawahOcular injury  ppt  Upendra pal  optometrist upums saifai etawah
Ocular injury ppt Upendra pal optometrist upums saifai etawah
 
Superficial & Deep Fascia of the NECK.pptx
Superficial & Deep Fascia of the NECK.pptxSuperficial & Deep Fascia of the NECK.pptx
Superficial & Deep Fascia of the NECK.pptx
 
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTSARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
 
Knee anatomy and clinical tests 2024.pdf
Knee anatomy and clinical tests 2024.pdfKnee anatomy and clinical tests 2024.pdf
Knee anatomy and clinical tests 2024.pdf
 
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists  Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
 
263778731218 Abortion Clinic /Pills In Harare ,
263778731218 Abortion Clinic /Pills In Harare ,263778731218 Abortion Clinic /Pills In Harare ,
263778731218 Abortion Clinic /Pills In Harare ,
 
Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...
Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...
Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...
 
Triangles of Neck and Clinical Correlation by Dr. RIG.pptx
Triangles of Neck and Clinical Correlation by Dr. RIG.pptxTriangles of Neck and Clinical Correlation by Dr. RIG.pptx
Triangles of Neck and Clinical Correlation by Dr. RIG.pptx
 

Building up a brand in an unprecedented environment

  • 1. Building up a brand in an unprecedented environment Nov.2016 A.Vogel in Greece
  • 2. 1 1. Introduction 2. The country: Greece [& Cyprus] 3. The organization: ICP 4. ICP„s strategy and implementation 5. Conclusion A.Vogel Brand Case Study
  • 3. 1 “History” / starting point 2009 A.D. 1.1 We are not allowed to forget our boundary conditions, and at the same time we have to keep handling “noise” caused by external factors. A.Vogel Brand Case Study
  • 4. A.Vogel Brand Case Study 1.2 Seven years ago we started structuring a new for the local standards model of organization, to deliver solutions to the health and beauty market. Some people said it couldn‟t be done! “When the going gets tough, the tough get going” Wall Street motto applicable to the current tough Greek reality
  • 5. 1 A.Vogel Brand Case Study 1.3 1. WHO: ICP 2. WHAT: Penetration / sustainability / growth of A.Vogel brand in Greece and Cyprus 3. WHERE: Greece and Cyrpus 4. WHEN: 2009 onwards 5. WHY: Function of [tradition, innovation, quality] 6. HOW: People mainly – because everything in life is developed / applied by people
  • 6. 1 ICP has managed to deliver Growth through: • disruption / “my way or highway” [Pat Riley] • innovation and • adaptability 1.4 A.Vogel Brand Case Study
  • 7. 1 The most rewarding things you do in life are often the ones that look like they cannot be done. Arnold Palmer 1.5 A.Vogel Brand Case Study
  • 8. 1 1.6 A.Vogel Brand Case Study Acropolis of Athens: the core element of the cradle of western civilization A.Vogel: the core element of both Bioforce and A.Vogel brand
  • 9. 1 The country 2.1 A.Vogel Brand Case Study [The bright side of it]
  • 10. 1 2.2 Greece‟s outlook / key facts • Even a “blind” person can easily realize that Greece is a place of testing “innovative” policies. • Population 10,8 million • GDP: 170 billion € [30% less than the beginning of crisis] • Number of pharmacies 10.300 • Average annual turnover of pharmacies has gone down to slightly above 400K € in 2015, from more than 700K € back in 2009, (fall in the range of 40%) A.Vogel Brand Case Study
  • 11. 1 Parameters / factors of the performance evaluation of a partner: - Quantitative: - Years of cooperation - GDP per capita variation - Population of the country - Qualitative: - Psychology - Stability of the country / market and risks associated 2.3 A.Vogel Brand Case Study
  • 12. 1 ICP Profile ICP commercializes top notch parapharmaceutical products of proven quality, safety and efficacy. Company Background: • Founded: 2003 • Based in Moschato, 5km from Acropolis • Golden section of mgt by objectives and mgt by example • 24 Employees, 16 of which with University degrees • Subdistributors: In Thessaloniki – 8 people (5 salesmen), Crete and Cyprus Portfolio of Innovative Products 10.300 pharmacies, out of which >3000 are ICP‟s customers Values: Integrity and Quality = Consistency and Continuity Mission: To offer safe, effective and or premium quality products to our customers / end-consumers in the area of nutritional / food supplements and parapharmaceuticals in general so as to fully cover their needs building a trustworthy and long- lasting relationship. To efficiently support our direct customers (pharmacists) contributing substantially in strengthening / enhancing their operation. Vision: To position / establish the brands of its portfolio in the market as the first choice in their respective categories and as a result to be regarded as the most reputable supplier in the field 3.1 A.Vogel Brand Case Study
  • 13. 1 Sales / scientific team of 13 persons (sales & medical rep) for Central-Southern Greece (external distributor for areas of Northern Greece & Crete) - Personnel visits both pharmacies and doctors - 2 people dedicated to doctors in private hospitals - Person who educates staff of key customers and communicates the brand values to consumers in large POS What substantially matters in an organization is whatever crosses its borders 3.2 A.Vogel Brand Case Study
  • 14. 1 ICP has “adopted” Alfred Vogel’s philosophy “We do not sell products – we offer services of high quality to both mid-customers and end-consumers.” [i.e. diffusion of knowledge / communication and relationships] 3.3 A.Vogel Brand Case Study
  • 16. 1 Ecosystem of ICP: Besides both suppliers and customers - Internal: Direct: - Management - Sales force - Business development - Marketing - Warehouse Indirect / outsourcing: - Legal - Logistics - Regulatory - Accounting - IT - Media / SoMe 3.5 A.Vogel Brand Case Study
  • 17. 1 Ecosystem of ICP: - External: - Market / end consumer - Competition - Regulatory authorities - Taxation / VAT 3.6 A.Vogel Brand Case Study
  • 18. 1 ICP adds significant value and support as a strategic partner to its customers and end-consumers People: we value people at every level who lead by example, take pride in what they do and inspire others. Teamwork: we value working together to achieve common goals which is the foundation of our success. Proven track record: demonstrated through past performance. Able to deliver an affordable solution without complexity: Ad-hoc brand management. Flexible and bespoke: listening to the exact needs. Work ethic: committed to excellence and how we achieve it. Integrity: we do what is right for our customers, clients and ourselves. 3.7 A.Vogel Brand Case Study
  • 19. 1 Our strong corporate values drive our business and we seek the same values in both our customers and suppliers 3.8 A.Vogel Brand Case Study
  • 20. 1 VISIONARY We think differently and are not afraid of competition. KNOWLEDGEABLE We have – considering our size – the strongest team in our field. Our language is confident but friendly. We avoid jargon and put the customer first. TRUSTWORTHY We are honest, approachable and engaging. The trusted company. HUMAN Our world revolves around our customers and their needs. 3.9 A.Vogel Brand Case Study ICP manages a wide portfolio of top-notch products.
  • 21. 1 Even in this turbulent business environment we do not stop investing: Internally: - people - infrastructure - IT Externally / in an organization what really matters is what it crosses its borders: - marketing - SoMe / particular emphasis If adjustment of costs is necessary this does not affect quality of service. 3.10 A.Vogel Brand Case Study
  • 22. 1 MARKETING ACTIVITIES A. ACTIVITIES MATERIALIZED RECENTLY: • Online marketing • Offline marketing • Above the line • Below the line B. Activities under consideration: • Same modus operandi taking into consideration certain constrains / restrictions Focus on quantifiable vs. non quantifiable means of marketing Evaluation of ROI = f[money, time, opportunity cost, effort, commitment] 3.11 A.Vogel Brand Case Study
  • 23. 1 SWOT analysis S [trenghts]: - The personnel of the company / synthesis of the team - The financial stability [zero debt] W [eaknesses]: - Different sites [mgt and warehouse] - Lag in execution / implementation through sub-distributors O [pportunities]: - Shift of consumers towards relative affordable products of undisputed quality - perception of the brand by still growing customer basis / pharmacists T [hreats]: - Ongoing crisis with considerable reduction of the purchasing power - New local players in the segment / local pharma companies adopt the widely applied trend of creation of OTC business units 3.12 A.Vogel Brand Case Study
  • 24. 1 Needs of the market / industry 4.1 A.Vogel Brand Case Study
  • 25. 1 Strong brands have to have clear positioning. A.Vogel brand is positioned between medicines and food supplements primarily because it is backed by science. 4.2 A.Vogel Brand Case Study
  • 26. 1 4.3 ICP vs A.Vogel A.Vogel Brand Case Study
  • 27. 1 With holistic and coherent approach With clear policy / planning With the right execution / implementation With the right people and mindset 4.4 A.Vogel Brand Case Study
  • 28. 1 The Strategy For a company to succeed, a clear pathway aligned to its business plan and strategy is key. The strategy is a vital component in the Company armory. It should have equal value and importance to the brands and their protection. 4.5 A.Vogel Brand Case Study
  • 29. 1 Where does the strategy start? Drill back down to what is important and what is valuable and start with two questions: What is my product?
 Where/what are the opportunities? Sounds simple but....! 4.6 A.Vogel Brand Case Study
  • 30. 1 The wider strategy What defines each? Who controls and regulates them? Our strategy is a three dimensional tool.  Level 1: Commercial – What is this we want to make happen?  Level 2: Geographical – Full coverage  Level 3: Steps - What are the clearly and precisely defined steps [KISS] to achieve this? 4.7 A.Vogel Brand Case Study
  • 31. 1 The wider strategy “If you know the enemy and know yourself, you need not fear the result of a hundred battles. If you know yourself but not the enemy, for every victory gained you will also suffer a defeat. If you know neither the enemy nor yourself, you will succumb in every battle.” Sun Tzu, The art of War 4.8 A.Vogel Brand Case Study
  • 32. 1 OPTION #1 If You sit down by a river bank, and wait long enough, You‟ll see bodies of Your enemies float by 4.9 A.Vogel Brand Case Study
  • 33. 1 OPTION #2 Master completely a different way of marketing 4.10 A.Vogel Brand Case Study
  • 34. 1 OPTION #3 Create ecosystems Ecosystems are determined by parameters - Fully controlled - Semi / quasi controlled - Non-controlled The goal has to be the optimization of the controlled and semi-controlled parameters so as to counterbalance the potential negative input from the non-controlled ones. 4.11 A.Vogel Brand Case Study
  • 35. 1 OPTION #4 Be the disruptor 4.12 A.Vogel Brand Case Study
  • 36. 1 OPTION #5 “Be the disruptor in things you control. Be adaptive to things you do not control.” - SM 4.13 A.Vogel Brand Case Study
  • 37. 1 A yearly planning cycle driven mainly by Marketing IMC [internal model control] vis a vis planning / perpetual trial and error process Brand plans Minor adjustments Trimester modifications Brand reconsideration 4.14 A.Vogel Brand Case Study
  • 39. 1 Right people / organization & mindset / implementation - execution 4.16 A.Vogel Brand Case Study The final part of the jigsaw – tactics – the way we implement it!
  • 40. 1 Brand overview / SWOT analysis S [trenghts]: - Knowledge of the caliber of the brand and its specific weight / “second nature” by ICP’s personnel W [eaknesses]: - Regulatory status O [pportunities]: - Optimization of the two parameter function of pricing and quality. - Perception from customers and consumers. T [hreats]: Constraints for efficient marketing due to regulation and operational gross margins 4.17 A.Vogel Brand Case Study
  • 41. 1 Dominant factors for the growth of the A.Vogel brand in our market: - Regulatory compliance [prerequisite] - Margins [financially coherent P&L] for supporting the efficient awareness and availability of the brand 4.18 A.Vogel Brand Case Study
  • 42. 1 CONCLUSIONS • People – People – People: the cornerstone / most critical parameter Give me the right people and I will accomplish [almost] everything. - SM [Give me a place to stand and I will move the world – Archimides] • Requirement for common sense [which is not that common], both inside and outside of ICP’s ecosystem • Capitalization on past experiences incorporating other partners’ policies “Man has always learnt from the past. After all, you can’t learn history in reverse.” – SM • “Ta panta rei” = [everything is under perpetual variation ie. nothing is constant / stable = dynamic and not static] -Heracletus • “I am pessimistic because I am pragmatic and optimistic because I dream.” - Noam Chomsky 5.1 A.Vogel Brand Case Study